Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 Dec;54(6):1382–1394. doi: 10.1172/JCI107885

Human Parathyroid Hormone IMMUNOLOGICAL CHARACTERIZATION OF ANTIBODIES AGAINST A GLANDULAR EXTRACT AND THE SYNTHETIC AMINO-TERMINAL FRAGMENTS 1-12 AND 1-34 AND THEIR USE IN THE DETERMINATION OF IMMUNOREACTIVE HORMONE IN HUMAN SERA

Jan A Fischer 1,2,3, Ulrich Binswanger 1,2,3, Felix M Dietrich 1,2,3
PMCID: PMC301693  PMID: 4474187

Abstract

Antibodies to a urea-trichloroacetic acid extract [hPTH-(TCA)] of human parathyroid tumors and to the synthetic NH2-terminal fragments of human parathyroid hormone hPTH-(1-12) and -(1-34) were developed in goats to characterize immunochemically various PTH preparations and to estimate immunoreactive PTH (iPTH) in human sera. They were quantitated on the basis of their capacity to bind [131I]-hPTH-(1-12), [131I]hPTH-(1-34) or [131I]bovine PTH (bPTH-(1-84)). The quality of the antibodies was assessed by reference to inhibition of their interaction with labeled peptides by synthetic hPTH comprising 34 NH2-terminal amino acid residues or fragments thereof [hPTH-(1-12), -(13-34), -(18-34), -(25-34), -(18-24)] or by the Sephadex G-100-purified full-length peptide hPTH-(1-84) [hPTH-(1-84)G-100]. The synthetic peptides used in this work correspond in their structure to the NH2-terminal amino acid sequence 1-34, as elucidated by Brewer and collaborators (1972. Proc. Natl. Acad. Sci. U. S. A.69: 3583-3588). Inhibition studies were also carried out with bPTH-(1-34) and bPTH-(1-84). Anti-hPTH-(TCA) exhibited specificities directed to determinants in the COOH-terminal and NH2-terminal part of hPTH-(1-84) and exhibited cross-reactivity with bPTH-(1-84). Anti-hPTH-(1-34), on the other hand, showed immunological specificities mainly directed to antigenic determinants located in the COOH-terminal half of hPTH-(1-34). In addition, some reactivity with the NH2-terminal hPTH-(1-12) and with the extractive full-length peptides of human and bovine origin was observed. Antibodies to hPTH-(1-12) cross-reacted with hPTH-(1-34) and -(1-84)G-100.

iPTH was radioimmunologically determined in human sera by the following systems: (a) [131I]bPTH-(1-84), anti-hPTH-(TCA) and hPTH-(1-84)G-100 as standard; (b) [131I]hPTH-(1-34), anti-hPTH-(1-34) and hPTH-(1-34) as standard. With system (a), COOH-terminal fragments of hPTH-(1-84) having a molecular weight of approximately 7,000 were detected, and there was an almost total discrimination of serum iPTH levels in normal and in hyperparathyroid subjects. With system (b), on the other hand, several molecular species of iPTH were detected, including a component larger than hPTH-(1-84) and others similar to hPTH-(1-84) and to a fragment co-eluting with the NH2-terminal fragment hPTH-(1-34). When serum iPTH was assayed in system (b), there was a large overlap of iPTH levels in control subjects and in patients with primary hyperparathyroidism.

Full text

PDF
1382

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aloj S., Edelhoch H. Structural studies on polypeptide hormones. II. Parathyroid hormone. Arch Biochem Biophys. 1972 Jun;150(2):782–785. doi: 10.1016/0003-9861(72)90098-7. [DOI] [PubMed] [Google Scholar]
  2. Andreatta R. H., Hartmann A., Jöhl A., Kamber B., Maier R., Riniker B., Rittel W., Sieber P. Synthese der Sequenz 1-34 von menschlichem Parat-hormon. Helv Chim Acta. 1973;56(1):470–473. doi: 10.1002/hlca.19730560139. [DOI] [PubMed] [Google Scholar]
  3. Arnaud C. D., Goldsmith R. S., Bordier P. J., Sizemore G. W. Influence of immunoheterogeneity of circulating parathyroid hormone on results of radioimmunoassays of serum in man. Am J Med. 1974 Jun;56(6):785–793. doi: 10.1016/0002-9343(74)90806-7. [DOI] [PubMed] [Google Scholar]
  4. Arnaud C. D., Sizemore G. W., Oldham S. B., Fischer J. A., Tsao H. S., Littledike E. T. Human parathyroid hormone: glandular and secreted molecular species. Am J Med. 1971 May;50(5):630–638. doi: 10.1016/0002-9343(71)90118-5. [DOI] [PubMed] [Google Scholar]
  5. Arnaud C. D., Tsao H. S., Littledike T. Radioimmunoassay of human parathyroid hormone in serum. J Clin Invest. 1971 Jan;50(1):21–34. doi: 10.1172/JCI106476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Arnaud C. D., Tsao H. S., Oldham S. B. Native human parathyroid hormone: an immunochemical investigation. Proc Natl Acad Sci U S A. 1970 Sep;67(1):415–422. doi: 10.1073/pnas.67.1.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Berson S. A., Yalow R. S. Immunochemical heterogeneity of parathyroid hormone in plasma. J Clin Endocrinol Metab. 1968 Jul;28(7):1037–1047. doi: 10.1210/jcem-28-7-1037. [DOI] [PubMed] [Google Scholar]
  8. Berson S. A., Yalow R. S. Iodoinsulin used to determine specific activity of iodine-131. Science. 1966 Apr 8;152(3719):205–207. doi: 10.1126/science.152.3719.205. [DOI] [PubMed] [Google Scholar]
  9. Berson S. A., Yalow R. S. Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia, and bronchogenic carcinoma. Science. 1966 Nov 18;154(3751):907–909. doi: 10.1126/science.154.3751.907. [DOI] [PubMed] [Google Scholar]
  10. Blair A. J., Jr, Hawker C. D., Utiger R. D. Ectopic hyperparathyroidism in a patient with metastatic hypernephroma. Metabolism. 1973 Feb;22(2):147–154. doi: 10.1016/0026-0495(73)90265-5. [DOI] [PubMed] [Google Scholar]
  11. Brewer H. B., Jr, Fairwell T., Rittel W., Littledike T., Arnaud C. D. Recent studies on the chemistry of human, bovine and porcine parathyroid hormones. Am J Med. 1974 Jun;56(6):759–766. doi: 10.1016/0002-9343(74)90803-1. [DOI] [PubMed] [Google Scholar]
  12. Brewer H. B., Jr, Fairwell T., Ronan R., Sizemore G. W., Arnaud C. D. Human parathyroid hormone: amino-acid sequence of the amino-terminal residues 1-34. Proc Natl Acad Sci U S A. 1972 Dec;69(12):3585–3588. doi: 10.1073/pnas.69.12.3585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Canterbury J. M., Levey G. S., Reiss E. Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments. J Clin Invest. 1973 Feb;52(2):524–527. doi: 10.1172/JCI107211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Canterbury J. M., Reiss E. Multiple immunoreactive molecular forms of parathyroid hormone in human serum. 1. Proc Soc Exp Biol Med. 1972 Sep;140(4):1393–1398. doi: 10.3181/00379727-140-36681. [DOI] [PubMed] [Google Scholar]
  15. Chu L. L., MacGregor R. R., Liu P. I., Hamilton J. W., Cohn D. V. Biosynthesis of proparathyroid hormone and parathyroid hormone by human parathyroid glands. J Clin Invest. 1973 Dec;52(12):3089–3094. doi: 10.1172/JCI107508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Conaway H. H., Anast C. S. Double-antibody radioimmunoassay for parathyroid hormone. J Lab Clin Med. 1974 Jan;83(1):129–138. [PubMed] [Google Scholar]
  17. Goldsmith R. S., Furszyfer J., Johnson W. J., Fournier A. E., Sizemore G. W., Arnaud C. D. Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility. J Clin Invest. 1973 Jan;52(1):173–180. doi: 10.1172/JCI107161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  19. Habener J. F., Kemper B., Potts J. T., Jr, Rich A. Proparathyroid hormone: biosynthesis by human parathyroid adenomas. Science. 1972 Nov 10;178(4061):630–633. doi: 10.1126/science.178.4061.630. [DOI] [PubMed] [Google Scholar]
  20. Habener J. F., Powell D., Murray T. M., Mayer G. P., Potts J. T., Jr Parathyroid hormone: secretion and metabolism in vivo. Proc Natl Acad Sci U S A. 1971 Dec;68(12):2986–2991. doi: 10.1073/pnas.68.12.2986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Habener J. F., Segre G. V., Powell D., Murray T. M., Potts J. T., Jr Immunoreactive parathyroid hormone in circulation of man. Nat New Biol. 1972 Aug 2;238(83):152–154. doi: 10.1038/newbio238152a0. [DOI] [PubMed] [Google Scholar]
  22. Herbert V., Lau K. S., Gottlieb C. W., Bleicher S. J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. doi: 10.1210/jcem-25-10-1375. [DOI] [PubMed] [Google Scholar]
  23. Lequin R. M., Hackeng W. H., Schopman W. A radioimmunoassay for parathyroid hormone in man. II. Measurement of parathyroid hormone concentrations in human plasma by means of a radioimmunoassay for bovine hormone. Acta Endocrinol (Copenh) 1970 Apr;63(4):655–666. [PubMed] [Google Scholar]
  24. Niall H. D., Sauer R. T., Jacobs J. W., Keutmann H. T., Segre G. V., O'Riordan J. L., Aurbach G. D., Potts J. T., Jr The amino-acid sequence of the amino-terminal 37 residues of human parathyroid hormone. Proc Natl Acad Sci U S A. 1974 Feb;71(2):384–388. doi: 10.1073/pnas.71.2.384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Potts J. T., Jr, Murray T. M., Peacock M., Niall H. D., Tregear G. W., Keutmann H. T., Powell D., Deftos L. J. Parathyroid hormone: sequence, synthesis, immunoassay studies. Am J Med. 1971 May;50(5):639–649. doi: 10.1016/0002-9343(71)90119-7. [DOI] [PubMed] [Google Scholar]
  26. RASMUSSEN H., SZE Y. L., YOUNG R. FURTHER STUDIES ON THE ISOLATION AND CHARACTERIZATION OF PARATHYROID POLYPEPTIDES. J Biol Chem. 1964 Sep;239:2852–2857. [PubMed] [Google Scholar]
  27. Reis E., Canterbury J. M. A radioimmunoassay for parathyroid hormone in man. Proc Soc Exp Biol Med. 1968 Jun;128(2):501–504. doi: 10.3181/00379727-128-33050. [DOI] [PubMed] [Google Scholar]
  28. Roof B. S., Gordan G. S., Goldman L., Piel C. F. Berson and Yalow's radioimmunoassay for parathyroid hormone (PTH): a clinical progress report. Mt Sinai J Med. 1973 May-Jun;40(3):433–447. [PubMed] [Google Scholar]
  29. Segre G. V., Habener J. F., Powell D., Tregear G. W., Potts J. T. Parathyroid Hormone in Human Plasma: IMMUNOCHEMICAL CHARACTERIZATION AND BIOLOGICAL IMPLICATIONS. J Clin Invest. 1972 Dec;51(12):3163–3172. doi: 10.1172/JCI107143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sherwood L. M., Rodman J. S., Lundberg W. B. Evidence for a precursor to circulating parathyroid hormone. Proc Natl Acad Sci U S A. 1970 Nov;67(3):1631–1638. doi: 10.1073/pnas.67.3.1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Silverman R., Yalow R. S. Heterogeneity of parathyroid hormone. Clinical and physiologic implications. J Clin Invest. 1973 Aug;52(8):1958–1971. doi: 10.1172/JCI107380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Studer O., Knob M., Binswanger U. Kalziumionenkonzentration im Serum. Befunde in zwei Altersklassen bei beiden Geschlectern: Beziehung zum Gesamtkalzium und ultrafiltrierbaren Kalzium: Resultate bei Dysfunktion der Nebenschiddrüsen. Schweiz Med Wochenschr. 1972 Mar 4;102(9):305–309. [PubMed] [Google Scholar]
  33. Tregear G. W., van Rietschoten J., Greene E., Niall H. D., Keutmann H. T., Parsons J. A., O'Riordan J. L., Potts J. T., Jr Solid-phase synthesis of the biologically active N-terminal 1 - 34 peptide of human parathyroid hormone. Hoppe Seylers Z Physiol Chem. 1974 Apr;355(4):415–421. doi: 10.1515/bchm2.1974.355.1.415. [DOI] [PubMed] [Google Scholar]
  34. YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES